Preterm labour at 34-36 weeks of gestation: should it be arrested?

被引:29
作者
Arnon, S
Dolfin, T
Litmanovitz, I
Regev, R
Bauer, S
Fejgin, M
机构
[1] Tel Aviv Univ, Sackler Sch Med, Meir Hosp, Sapir Med Ctr,Dept Neonatol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Meir Hosp, Sapir Med Ctr,Dept Obstet & Gynecol, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1046/j.1365-3016.2001.00357.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Currently, preterm labour is treated with tocolytic agents and prenatal steroids until the 34th week of gestation only. Our objective in this study was to assess this practice. Seven-year records of all preterm infants born in our institution at 34-36 weeks of gestation, were evaluated retrospectively. All babies, born in singleton well-dated pregnancies, without maternal, medical or obstetric complications, and by normal vaginal delivery, were included. Their length of hospital stay and perinatal complications were compared across gestational age groups of 34, 35 and 36 weeks. Of the 207 babies included, statistically significant reductions in the rates of respiratory distress syndrome (15.0% vs. 3.2%), nosocomial sepsis (5.0% vs. 0%) and apnoea of prematurity (11.7% vs. 2.2%), and consequently, in length of hospital stay (16 +/- 2.7 vs. 4 +/- 0.3 days) occurred between 34 and 36 weeks of gestation. The severity of respiratory distress syndrome also declined significantly. The changes were most noticeable after 35 weeks of gestation, and it was concluded that neonatal complications are still prevalent at 34 and 35 weeks. Therefore, we propose that labour should not be induced at 34 and 35 weeks of gestation and that tocolytic agents and maternal prenatal steroids may be considered in preterm labour during this period.
引用
收藏
页码:252 / 256
页数:5
相关论文
共 19 条
[1]   Fatal sepsis due to Escherichia coli after second-trimester amniocentesis [J].
Ayadi, S ;
Carbillon, L ;
Varlet, C ;
Uzan, M ;
Pourriat, JL .
FETAL DIAGNOSIS AND THERAPY, 1998, 13 (02) :98-99
[2]   NEW BALLARD SCORE, EXPANDED TO INCLUDE EXTREMELY PREMATURE-INFANTS [J].
BALLARD, JL ;
KHOURY, JC ;
WEDIG, K ;
WANG, L ;
EILERSWALSMAN, BL ;
LIPP, R .
JOURNAL OF PEDIATRICS, 1991, 119 (03) :417-423
[3]   A MULTICENTER STUDY OF PRETERM BIRTH-WEIGHT AND GESTATIONAL-AGE SPECIFIC NEONATAL-MORTALITY [J].
COPPER, RL ;
GOLDENBERG, RL ;
CREASY, RK ;
DUBARD, MB ;
DAVIS, RO ;
ENTMAN, SS ;
IAMS, JD ;
CLIVER, SP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) :78-84
[4]   ANTENATAL CORTICOSTEROID-THERAPY - A METAANALYSIS OF THE RANDOMIZED TRIALS, 1972 TO 1994 [J].
CROWLEY, PA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (01) :322-335
[5]   BIRTH-WEIGHT THRESHOLD FOR POSTPONING PRETERM BIRTH [J].
DEPALMA, RT ;
LEVENO, KJ ;
KELLY, MA ;
SHERMAN, ML ;
CARMODY, TJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (04) :1145-1149
[6]  
Fox M D, 1993, J Perinatol, V13, P349
[7]  
GILSTRAP LC, 1995, AM J OBSTET GYNECOL, V173, P246
[8]   Medical progress - Prevention of premature birth [J].
Goldenberg, RL ;
Rouse, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :313-320
[9]  
GOLDENBERG RL, 1984, OBSTET GYNECOL, V64, P480
[10]   DO TOCOLYTIC AGENTS STOP PRETERM LABOR - A CRITICAL AND COMPREHENSIVE REVIEW OF EFFICACY AND SAFETY [J].
HIGBY, K ;
XENAKIS, EMJ ;
PAUERSTEIN, CJ ;
HARBERT, GM ;
JONES, H ;
MERKATZ, IR ;
CREASY ;
WOODS, J ;
CEFALO, RC ;
GIBBS, RS ;
SCOTT, S ;
QUEENAN, JT ;
KIRSCHBAUM ;
NELSON, K .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (04) :1247-1259